BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31345225)

  • 1. SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways.
    Yang Y; Liang Z; Xia Z; Wang X; Ma Y; Sheng Z; Gu Q; Shen G; Zhou L; Zhu H; Xu N; Liang S
    Cell Commun Signal; 2019 Jul; 17(1):82. PubMed ID: 31345225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved EMT in hepatocellular carcinoma.
    Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
    Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS-mediated up-regulation of SAE1 by Helicobacter pylori promotes human gastric tumor genesis and progression.
    Shi L; Shangguan J; Lu Y; Rong J; Yang Q; Yang Y; Xie C; Shu X
    J Transl Med; 2024 Feb; 22(1):148. PubMed ID: 38351014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Small Ubiquitin-like Modifier-Activating Enzyme SAE1 Promotes Hepatocellular Carcinoma by Enhancing mTOR SUMOylation.
    Chen Y; Peng W; Tao Q; Li S; Wu Z; Zhou Y; Xu Q; Shu Y; Xu Y; Shao M; Chen M; Shi Y
    Lab Invest; 2023 Jan; 103(1):100011. PubMed ID: 36748193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
    Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
    J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased SUMO-activating enzyme SAE1/UBA2 promotes glycolysis and pathogenic behavior of rheumatoid fibroblast-like synoviocytes.
    Wang C; Xiao Y; Lao M; Wang J; Xu S; Li R; Xu X; Kuang Y; Shi M; Zou Y; Wang Q; Liang L; Zheng SG; Xu H
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32938830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic Cancer Metabolism Biomarker of Hepatocellular Carcinoma.
    Ong JR; Bamodu OA; Khang NV; Lin YK; Yeh CT; Lee WH; Cherng YG
    Cells; 2021 Jan; 10(1):. PubMed ID: 33477333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA BCAR4 promotes glioma cell proliferation via EGFR/PI3K/AKT signaling pathway.
    Wei L; Yi Z; Guo K; Long X
    J Cell Physiol; 2019 Dec; 234(12):23608-23617. PubMed ID: 31173355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prefoldin 6 promotes glioma progression via the AKT signalling pathway.
    Jiang L; Liu J
    Cell Biol Int; 2023 Jan; 47(1):52-62. PubMed ID: 36300673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lentivirus-mediated siRNA targeting sae1 induces cell cycle arrest and apop- tosis in colon cancer cell RKO].
    Song N; Gu x-; Wang Y; Chen Z-; Shi L-
    Mol Biol (Mosk); 2014; 48(1):107-16. PubMed ID: 25842831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme.
    Mohajerani F; Tehrankhah ZM; Rahmani S; Afsordeh N; Shafiee S; Pourgholami MH; Soltani BM; Sadeghizadeh M
    BMC Cancer; 2024 Jan; 24(1):19. PubMed ID: 38167030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXN3 inhibits cell proliferation and invasion via modulating the AKT/MDM2/p53 axis in human glioma.
    Wang C; Tu H; Yang L; Ma C; Hu J; Luo J; Wang H
    Aging (Albany NY); 2021 Sep; 13(17):21587-21598. PubMed ID: 34511432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-382-3p downregulation contributes to the carcinogenesis of lung adenocarcinoma by promoting AKT SUMOylation and phosphorylation.
    Fang H; Wu W; Wu Z
    Exp Ther Med; 2022 Jul; 24(1):440. PubMed ID: 35720620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.
    Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR
    Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
    Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
    Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
    Mu M; Niu W; Zhang X; Hu S; Niu C
    Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt SUMOylation regulates cell proliferation and tumorigenesis.
    Li R; Wei J; Jiang C; Liu D; Deng L; Zhang K; Wang P
    Cancer Res; 2013 Sep; 73(18):5742-53. PubMed ID: 23884910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.